Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Return on Assets (2021 - 2026)

Unicycive Therapeutics filings provide 3 years of Return on Assets readings, the most recent being 0.01% for Q4 2024.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.01% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.01%, a 0.0% change, with the full-year FY2024 number at 0.01%, up 1.0% from a year prior.
  • Return on Assets hit 0.01% in Q4 2024 for Unicycive Therapeutics, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q2 2024 to a low of 0.03% in Q4 2022.
  • Median Return on Assets over the past 3 years was 0.01% (2023), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Assets: up 2bps in 2023, down 0bps in 2023.
  • Unicycive Therapeutics' Return on Assets stood at 0.03% in 2022, then skyrocketed by 57bps to 0.01% in 2023, then grew by 27bps to 0.01% in 2024.
  • The last three reported values for Return on Assets were 0.01% (Q4 2024), 0.01% (Q3 2024), and 0.01% (Q2 2024) per Business Quant data.